Treatment options for malignant pleural effusion

  • Musani A
  • 1

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

PURPOSE OF REVIEW: Thirty percent of lung cancers eventually result in malignant pleural effusion (MPE). Devastating consequences of MPE, such as dyspnea and cough, severely deteriorate the quality of life of these patients. Malignant pleural effusion portends a dismal prognosis of less than 6-month longevity, with the exception of breast and ovarian cancer. Given the poor prognosis of the majority of these patients, palliation, rather than cure, should be the goal of therapy. RECENT FINDINGS: Chest tube insertion and sclerotherapy remain the standard of care. Emerging therapeutic options such as medical pleuroscopy and indwelling pleural catheters offer cost-effective and outpatient treatments for MPE. SUMMARY: In the following review, the medical, economic, and social aspects of different current options for the management of MPE are discussed.

Author-supplied keywords

  • Algorithms
  • Catheters, Indwelling
  • Chest Tubes
  • Humans
  • Pleural Effusion, Malignant/ therapy
  • Pleurodesis/methods
  • Sclerotherapy/methods
  • Thoracoscopy/methods

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Authors

  • A I Musani

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free